http://www.raredr.com/conferences/ash-2016/economic-toxicities-and-myeloproliferative-neoplasms
Job Security and Rare Blood Disorders

Ruben Mesa, MD




Ruben Mesa, MD of the Mayo Clinic in Scottsdale, AZ talks about the data he presented at the 58th Annual ASH Meeting & Exposition showing that half of the patients  with myeloproliferative neoplasms (MPNs), including myelofibrosis, polycythemia vera, and essential thrombocythemia had to change their employment status (eg, leaving job, medical disability leave, early retirement) due to their rare disease.

Reference

Yu J, Parasuraman S, Paranagama D, et al.  Impact of Myeloproliferative Neoplasms on Patients’ Employment Status and Work Productivity in the United States: Results from the Living with MPN Patient Survey. Presented at the 58th Annual ASH Meeting & Exposition; San Diego, CA; December 3-6, 2016. Abstract 4256.
 
 
Printer Printing...
$content$